BAC
Bank of America Corporation
BAC has the edge over ISBA overall, supported by stronger valuation and stronger modeled upside.
ISBA
Isabella Bank Corporation
ISBA trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ISBA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ISBA's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ISBA.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ISBA in the historical PE scenario, which offers more potential upside but is not a forecast.
ISBA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $23.34 | -41% |
| Forward | 11x | $39.60 | — |
| Fair | 12x | $35.44 | -11% |
| Current | 14x | $39.60 | — |
| Expensive | 16x | $44.67 | +13% |
Historical ranges are pointers, not guarantees.
ISBA's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ISBA on the outlook, with more favorable profitability expectations.
ISBA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ISBA, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
ISBA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.65 | +27% |
| Q3 2026 | $2.87 | +17% |
| Q2 2026 | $2.72 | +24% |
| Q1 2026 | $2.71 | +38% |
| Q4 2025 | $2.56 | +38% |
| Q3 2025 | $2.46 | +34% |
| Q2 2025 | $2.19 | +11% |
| Q1 2025 | $1.97 | -7.1% |
| Q4 2024 | $1.86 | -22% |
ISBA earned $2.87 per share over the past year, up 17% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ISBA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.9M | +17% |
| Q2 2026 | $22.5M | +19% |
| Q1 2026 | $21.2M | +18% |
| Q4 2025 | $21.2M | +14% |
| Q3 2025 | $20.5M | +14% |
| Q2 2025 | $18.8M | +9.7% |
| Q1 2025 | $18.1M | +8% |
| Q4 2024 | $18.5M | +8.2% |
ISBA has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | +3.8 points |
| Q2 2026 | 28% | -5.3 points |
| Q1 2026 | 28% | +1.2 points |
| Q4 2025 | 32% | +6.2 points |
| Q3 2025 | 31% | +9.3 points |
| Q2 2025 | 33% | +8.9 points |
| Q1 2025 | 27% | +5.1 points |
| Q4 2024 | 26% | -0.4 points |
ISBA has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ISBA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.9M | +181% |
| Q2 2026 | $7.3M | +0.8% |
| Q1 2026 | $3.2M | -13% |
| Q4 2025 | $10.6M | +61% |
| Q3 2025 | $1.7M | -49% |
| Q2 2025 | $7.2M | +44% |
| Q1 2025 | $3.7M | +47% |
| Q4 2024 | $6.6M | +62% |
ISBA has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ISBA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ISBA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.2% | +306K shares |
| 1 year | +3.7% | +271K shares |
| 3 years | +1% | +72.5K shares |
| 5 years | -5% | -402K shares |
| Available history | -5.6% | -452K shares |
ISBA has 8M diluted shares, up 3.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $136,000 |
| Q2 2026 | $224,000 |
| Q1 2026 | $402,000 |
| Q4 2025 | $1.5M |
| Q3 2025 | $609,000 |
| Q2 2025 | $1.5M |
| Q1 2025 | $1.1M |
| Q3 2024 | $1M |
ISBA spent $2M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ISBA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.7x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | -5.4x | Net Cash |
| Q2 2025 | -3.6x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | 0.3x | Very low |
ISBA has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ISBA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 61.5 | Neutral |
ISBA's weekly RSI is 49 (neutral) and its Stochastic is 61 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over ISBA on valuation relative to its sector.
ISBA PE vs Financial Services Sector
| Metric | ISBA | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 6% above |
| PE % | 62 | 63 | 1 pt below |
ISBA is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ISBA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.6 | 2.5% above |
| 20 week MA | $39.2 | 1.1% above |
| 50 week MA | $43.4 | 8.8% below |
| 100 week MA | $36.8 | 7.7% above |
| 200 week MA | $28.9 | 37% above |
ISBA has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over ISBA on returns for 2026, with the stronger performance.
ISBA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.2 | $19.8 | -18% |
| 2021 | $19.8 | $26.3 | +33% |
| 2022 | $26.3 | $23.0 | -13% |
| 2023 | $23.0 | $21.5 | -6.5% |
| 2024 | $21.5 | $26.0 | +21% |
| 2025 | $26.0 | $51.6 | +99% |
| 2026 YTD | $51.6 | $39.6 | -23% |
ISBA has finished lower in three of the last six years. It's down 23% so far in 2026.